PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea.

However, although PSGL-1 axis blockade induce a tendency to proliferation recovery, it did not reach statistical significance ( Figure 4B ).

also in 111,027 other papers